Skip to content
Le Territoire Médical

WHO Model List

simvastatin

International nonproprietary name (English: simvastatin). Brand names vary by country.

Indications retained by WHO

Mixed hyperlipidaemia; Coronary atherosclerosis; Polycystic ovary syndrome.

Listed forms and strengths

  • Oral > Solid: 5 mg; 10 mg; 20 mg; 40 mg
  • Oral > Solid: 20 mg

Forms retained in the model list; presentations available in each country may differ.

General information from the WHO list. It replaces neither the prescription nor the leaflet: dosage and duration are for the doctor or pharmacist to decide.

Source: WHO electronic Essential Medicines List (2025 edition), checked on 13/11/2026. An error or an imprecision? Let us know